MX2010004110A - Formulacion para mejorar la funcion gastrointestinal. - Google Patents

Formulacion para mejorar la funcion gastrointestinal.

Info

Publication number
MX2010004110A
MX2010004110A MX2010004110A MX2010004110A MX2010004110A MX 2010004110 A MX2010004110 A MX 2010004110A MX 2010004110 A MX2010004110 A MX 2010004110A MX 2010004110 A MX2010004110 A MX 2010004110A MX 2010004110 A MX2010004110 A MX 2010004110A
Authority
MX
Mexico
Prior art keywords
formulation
gastrointestinal function
improve gastrointestinal
subject invention
compositions
Prior art date
Application number
MX2010004110A
Other languages
English (en)
Inventor
Josef Neu
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of MX2010004110A publication Critical patent/MX2010004110A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención provee composiciones, y usos de las mismas, que mejoran la función gastrointestinal; las composiciones y métodos de la presente invención son particularmente ventajosos para uso con neonatos debido a que pueden ser utilizados para estimular el desarrollo del intestino inmaduro con el fin de proveer una capacidad intensificada para absorber nutrientes y lograr una función de barrera más fuerte.
MX2010004110A 2007-10-14 2008-10-14 Formulacion para mejorar la funcion gastrointestinal. MX2010004110A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97984507P 2007-10-14 2007-10-14
PCT/US2008/079849 WO2009052106A2 (en) 2007-10-14 2008-10-14 Formulation to improve gastrointestinal function

Publications (1)

Publication Number Publication Date
MX2010004110A true MX2010004110A (es) 2010-07-28

Family

ID=40568048

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004110A MX2010004110A (es) 2007-10-14 2008-10-14 Formulacion para mejorar la funcion gastrointestinal.

Country Status (8)

Country Link
US (1) US9107894B2 (es)
EP (1) EP2205235A4 (es)
CN (1) CN101896176A (es)
BR (1) BRPI0818669A2 (es)
CA (1) CA2703042A1 (es)
MX (1) MX2010004110A (es)
RU (1) RU2010119238A (es)
WO (1) WO2009052106A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110086809A1 (en) * 2009-10-14 2011-04-14 Joshua Anthony Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development
WO2016050752A1 (en) * 2014-09-30 2016-04-07 Nestec S.A. Nutritional composition for use in promoting gut and/or liver maturation and/or repair
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
IT201700050442A1 (it) * 2017-05-10 2018-11-10 Fusion Farm S R L Composizione per la prevenzione del danno intestinale
CN107736614A (zh) * 2017-08-29 2018-02-27 上海市儿科医学研究所 含丁酸的营养制剂
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
BE1027357B1 (nl) * 2019-06-12 2021-01-18 Vanlommel Maria Kristel Voedingssupplement voor versnelde genezing
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229136A (en) * 1992-05-21 1993-07-20 Clintec Nutrition Co. Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
PT1065947E (pt) * 1998-03-31 2003-08-29 Nestle Sa Metodo de administracao de glutamina
DE10057290B4 (de) 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US20060229256A1 (en) * 2003-09-26 2006-10-12 Bristol-Myers Squibb Company Enternal administration of arginine and glutamine for abnormal vascular proliferation

Also Published As

Publication number Publication date
WO2009052106A3 (en) 2009-06-04
CN101896176A (zh) 2010-11-24
EP2205235A4 (en) 2010-11-17
WO2009052106A2 (en) 2009-04-23
BRPI0818669A2 (pt) 2017-05-02
CA2703042A1 (en) 2009-04-23
EP2205235A2 (en) 2010-07-14
RU2010119238A (ru) 2011-11-27
US20100222271A1 (en) 2010-09-02
US9107894B2 (en) 2015-08-18

Similar Documents

Publication Publication Date Title
MX2010004110A (es) Formulacion para mejorar la funcion gastrointestinal.
IL271132A (en) New preparation and dosage
IL206288A0 (en) Novel dosage and formulation
IN2012DN02046A (es)
IL213365A (en) Imidazopyrazine and their pharmaceutical preparations
ZA201003761B (en) Polysaccharide gel formulation
EP2342239A4 (en) HIGHLY pure IONOMER COMPOSITIONS AND ARTICLES THEREWITH
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
HK1139864A1 (en) Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
EP2114429A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING CANCER WITH CUPREDOXINS
IL205713A0 (en) Afucosylated antibodies against ccr5 and their use
IL213043A0 (en) Lantibiotic carboxyamide derivatives, compositions comprising the same and uses thereof
HK1182934A1 (zh) 種抗疲勞的組合物及其製劑和應用
IL211204A0 (en) Mucoadherents compositions and their use
PL2646520T3 (pl) Kompozycja na bazie 1,1,1,4,4,4-heksafluorobut-2-enu i 3,3,4,4,4-pentafluorobut-1-enu
HK1149498A1 (en) Selenium containing modifying agents and conjugates
GB2472324A8 (en) Improvements in and relating to pharmaceutical compositions.
EP2376549A4 (en) HIGH CLARITY IONOMER MIXTURE COMPOSITIONS AND ARTICLES COMPRISING THE SAME
AU321401S (en) Packaging
AU322349S (en) Vial
EP2260046A4 (en) COMPOSITIONS WITH CERTAIN METALOCENES AND THEIR USE
IL213636A0 (en) Compositions and methods to prevent cancer with cupredoxins
TR200909786A1 (tr) Sefiksim içeren efervesan tablet ve granül formülasyonu.
IL218869A0 (en) Oligomer-calcimimetic conjugates,compositions comprising the same and uses thereof
IL213657A0 (en) Compositions and methods to prevent cancer with cupredoxins

Legal Events

Date Code Title Description
FA Abandonment or withdrawal